Pre-approval access: to clinical trials (including cross-border, pre-approval, post-approval, and advocacy action

Presentation at the WECAN Academy 2019:

Pre-approval access: to clinical trials (including cross-border, pre-approval, post-approval, and advocacy action

Presenter: Bettina Ryll, Melanoma Patients Network Europe & Holly Lumgair, Clinigen & Gilly Spurrier, Melanoma Patients Network Europe & Violeta Astratinei, Melanoma Patients Network Europe

The following presentation held at the WECAN Academy 2019 will help you to understand:

  • Why this is important – including the analysis of access issues that a patient advocacy group faces
  • Overview of Early Access mechanisms, how they work, the main areas to consider, including the possibilities and the challenges.
  • Perspective on access to clinical trials
  • Introduction to the situation about CEE access, especially when it comes to ways to manage funding issues

 

Last updated byJan
256 reads
Was this article of help to you?0000

Leave A Comment